Literature DB >> 31232668

Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous.

Jarred P Reed1, Edwin M Posadas1, Robert A Figlin1.   

Abstract

Entities:  

Year:  2019        PMID： 31232668     DOI： 10.1200/JCO.19.00639

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.

Authors:  Hamid Emamekhoo; Mark R Olsen; Bradley C Carthon; Alexandra Drakaki; Ivor J Percent; Ana M Molina; Daniel C Cho; Johanna C Bendell; Lucio N Gordan; Arash Rezazadeh Kalebasty; Daniel J George; Thomas E Hutson; Edward R Arrowsmith; Joshua Zhang; Jesus Zoco; Jennifer L Johansen; David K Leung; Scott S Tykodi
Journal:  Cancer       Date:  2021-11-16       Impact factor: 6.921

Review 2.  Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons.

Authors:  Elisa Aquilanti; Priscilla K Brastianos
Journal:  Neurosurgery       Date:  2020-09-01       Impact factor: 5.315

Review 3.  Immunotherapy of brain metastases: breaking a "dogma".

Authors:  Anna Maria Di Giacomo; Monica Valente; Alfonso Cerase; Maria Fortunata Lofiego; Francesca Piazzini; Luana Calabrò; Elisabetta Gambale; Alessia Covre; Michele Maio
Journal:  J Exp Clin Cancer Res       Date:  2019-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.